We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Image Processing Software Detects Ischemic Stroke

By HospiMedica International staff writers
Posted on 11 Mar 2021
A new artificial intelligence (AI) solution assesses cerebrovascular status by quantifying computerized tomography (CT) perfusion scans.

The icometrix (Leuven, Belgium) icobrain cva is a cloud-based solution designed to provide fully-automated software reports on lesion core volume and perfusion by quantifying Tmax abnormality and cerebral blood flow (CBF) abnormality, and correlation with the mismatch in volume and ratio; providing an arterial input function/venous output function (AIF/VOF) graph; and providing insights into the perfusion state of the tissue through perfusion maps.

The analysis provides color-coded segmentation, and also includes information on the correctness of the selected arterial input function and the quality of the output. More...
Both the report and the perfusion maps can be delivered directly to the picture archiving and communication systems (PACS) and to and e-mail inbox. The automated assessment of tissue parameters in an acute clinical setting can improve patient outcomes and care by ensuring they get the right treatment (thrombectomy, blood thinners, etc.) in a timely manner.

“With the launch of icobrain cva we address a persisting need in the treatment of acute ischemic stroke,” said Wim Van Hecke, CEO of icometrix. “By democratizing advanced CT perfusion analysis for healthcare systems worldwide, we take the next step in our mission to become a holistic brain solution provider.”

Rapid and effective revascularization is the mainstay of acute ischemic stroke treatment. Until recently, intravenous recombinant tissue-type plasminogen activator (r-tPA) was the only established therapeutic option. New studies have proven the benefit of endovascular treatment, and thrombectomy with stent retrievers is now recommended as the standard of care for acute ischemic strokes with a proximal large vessel occlusion in the anterior circulation.

Related Links:
Icometrix


Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
12-Channel ECG
CM1200B
OR Table Accessory
Angular Accessory Rail
Premium Air-Mattress
MA-51
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.